Mydecine Innovations Group Inc. (MYCOF)
OTCMKTS · Delayed Price · Currency is USD
0.0027
-0.0038 (-58.33%)
At close: Aug 22, 2025
MYCOF Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| - | - | - | - | 0.01 | 0 | Upgrade | |
Revenue Growth (YoY) | - | - | - | - | 186.32% | -97.92% | Upgrade |
Gross Profit | - | - | - | - | 0.01 | 0 | Upgrade |
Selling, General & Admin | 1.73 | 2.49 | 8.3 | 12.2 | 15.05 | 7.42 | Upgrade |
Research & Development | -1.52 | - | 1.08 | 3.51 | 3.96 | 1.29 | Upgrade |
Other Operating Expenses | - | - | - | - | - | 0.16 | Upgrade |
Operating Expenses | 0.22 | 2.49 | 9.39 | 15.84 | 22.34 | 11.42 | Upgrade |
Operating Income | -0.22 | -2.49 | -9.39 | -15.84 | -22.33 | -11.42 | Upgrade |
Interest Expense | -1.01 | -1.45 | -1.3 | -0.91 | -0.21 | -0.02 | Upgrade |
Currency Exchange Gain (Loss) | 0.06 | -0.32 | -0 | -0.18 | -0.36 | -0.11 | Upgrade |
Other Non Operating Income (Expenses) | 0.1 | 0.1 | -3.88 | 0.54 | -0.31 | 0.32 | Upgrade |
EBT Excluding Unusual Items | -1.08 | -4.15 | -14.58 | -16.39 | -23.2 | -11.23 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -4.75 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -5.14 | 0.96 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 0.05 | 0.05 | - | -0.32 | - | - | Upgrade |
Asset Writedown | - | - | - | - | - | -0.28 | Upgrade |
Other Unusual Items | 1.25 | 0.95 | -1.23 | - | -0.38 | -10.61 | Upgrade |
Pretax Income | 0.22 | -3.15 | -20.95 | -15.75 | -23.58 | -26.88 | Upgrade |
Earnings From Continuing Operations | 0.22 | -3.15 | -20.95 | -15.75 | -23.58 | -26.88 | Upgrade |
Earnings From Discontinued Operations | - | - | - | 6.5 | -5.31 | -0.07 | Upgrade |
Net Income | 0.22 | -3.15 | -20.95 | -9.25 | -28.9 | -26.95 | Upgrade |
Net Income to Common | 0.22 | -3.15 | -20.95 | -9.25 | -28.9 | -26.95 | Upgrade |
Shares Outstanding (Basic) | 62 | 60 | 31 | 9 | 5 | 2 | Upgrade |
Shares Outstanding (Diluted) | 62 | 60 | 31 | 9 | 5 | 2 | Upgrade |
Shares Change (YoY) | 27.26% | 94.24% | 254.98% | 84.71% | 105.86% | 410.54% | Upgrade |
EPS (Basic) | 0.00 | -0.05 | -0.68 | -1.07 | -6.17 | -11.85 | Upgrade |
EPS (Diluted) | 0.00 | -0.05 | -0.68 | -1.07 | -6.17 | -11.85 | Upgrade |
Free Cash Flow | -0.01 | -0.04 | -4.22 | -8.43 | -24.34 | -7.42 | Upgrade |
Free Cash Flow Per Share | - | -0.00 | -0.14 | -0.97 | -5.20 | -3.26 | Upgrade |
Gross Margin | - | - | - | - | 100.00% | 100.00% | Upgrade |
Operating Margin | - | - | - | - | -298069.65% | -436207.07% | Upgrade |
Profit Margin | - | - | - | - | -385658.60% | -1029764.81% | Upgrade |
Free Cash Flow Margin | - | - | - | - | -324889.79% | -283414.75% | Upgrade |
EBITDA | - | -2.48 | -9.38 | -15.71 | -22.19 | -11.24 | Upgrade |
D&A For EBITDA | - | 0.01 | 0.01 | 0.13 | 0.15 | 0.17 | Upgrade |
EBIT | -0.22 | -2.49 | -9.39 | -15.84 | -22.33 | -11.42 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.